Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raul Weiss

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Journal of the American College of Cardiology|April 25, 2015
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS RegistryMartin C Burke, Michael R Gold, Bradley P Knight, et al.
Journal of Cardiovascular Electrophysiology|September 11, 2019
RIsk Stratification prior to lead Extraction and impact on major intraprocedural complications (RISE protocol)Muhammad R Afzal, Emile G Daoud, Nancy Matre, et al.
Journal of the American Heart Association|August 2, 2015
Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic FunctionRyan G Aleong, Matthew J Mulvahill, Indrani Halder, et al.
The American Journal of Cardiology|February 16, 2015
Effect of angiotensin-converting enzyme inhibitors and receptor blockers on appropriate implantable cardiac defibrillator shock in patients with severe systolic heart failure (from the GRADE Multicenter Study)Wael A AlJaroudi, Marwan M Refaat, Robert H Habib, et al.
Heart Rhythm|October 19, 2011
Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathyMarwan M Refaat, Steven A Lubitz, Seiko Makino, et al.
Heart Rhythm|April 22, 2021
Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patientsMikhael F El-Chami, Caroline M Jacobsen, Robert I Griffiths, et al.
Circulation|October 31, 2007
Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmiasBarry London, Michael Michalec, Haider Mehdi, et al.
Circulation|July 28, 2016
Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human HeartNing Li, Thomas A Csepe, Brian J Hansen, et al.
Journal of the American College of Cardiology|July 26, 2023
Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator SystemMichael R Gold, Mikhael F El-Chami, Martin C Burke, et al.
Journal of the American Heart Association|September 2, 2017
Three-dimensional Integrated Functional, Structural, and Computational Mapping to Define the Structural "Fingerprints" of Heart-Specific Atrial Fibrillation Drivers in Human Heart Ex VivoJichao Zhao, Brian J Hansen, Yufeng Wang, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Journal of the American College of Cardiology|April 25, 2015
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS RegistryMartin C Burke, Michael R Gold, Bradley P Knight, et al.
Journal of Cardiovascular Electrophysiology|September 11, 2019
RIsk Stratification prior to lead Extraction and impact on major intraprocedural complications (RISE protocol)Muhammad R Afzal, Emile G Daoud, Nancy Matre, et al.
Journal of the American Heart Association|August 2, 2015
Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic FunctionRyan G Aleong, Matthew J Mulvahill, Indrani Halder, et al.
The American Journal of Cardiology|February 16, 2015
Effect of angiotensin-converting enzyme inhibitors and receptor blockers on appropriate implantable cardiac defibrillator shock in patients with severe systolic heart failure (from the GRADE Multicenter Study)Wael A AlJaroudi, Marwan M Refaat, Robert H Habib, et al.
Heart Rhythm|October 19, 2011
Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathyMarwan M Refaat, Steven A Lubitz, Seiko Makino, et al.
Heart Rhythm|April 22, 2021
Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patientsMikhael F El-Chami, Caroline M Jacobsen, Robert I Griffiths, et al.
Circulation|October 31, 2007
Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmiasBarry London, Michael Michalec, Haider Mehdi, et al.
Circulation|July 28, 2016
Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human HeartNing Li, Thomas A Csepe, Brian J Hansen, et al.
Journal of the American College of Cardiology|July 26, 2023
Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator SystemMichael R Gold, Mikhael F El-Chami, Martin C Burke, et al.
Journal of the American Heart Association|September 2, 2017
Three-dimensional Integrated Functional, Structural, and Computational Mapping to Define the Structural "Fingerprints" of Heart-Specific Atrial Fibrillation Drivers in Human Heart Ex VivoJichao Zhao, Brian J Hansen, Yufeng Wang, et al.
Pageof 11